Obesogens: An Environmental Link to Obesity by Holtcamp, Wendee
News | FocusFocus
Obesity is rising steadily around the world. Convincing evidence suggests that diet and 
activity level are not the only factors in this trend—chemical “obesogens” may alter human 
metabolism and predispose some people to gain weight. Fetal and early-life exposures to 
certain obesogens may alter some individuals’ metabolism and fat-cell makeup for life. 
Other obesogenic effects are linked to adulthood exposures.
O
besity has risen steadily in the United States over the past 
150 years,
1 with a marked uptick in recent decades.
2 In the 
United States today more than 35% of adults
3 and nearly 
17% of children aged 2–19 years are obese.
4 Obesity plagues 
people not just in the United States but worldwide, including, 
increasingly, developing countries.
5 Even animals—pets, 
laboratory animals, and urban rats—have experienced increases 
in average body weight over the past several decades,
6 trends not necessarily explained by 
diet and exercise. In the words of Robert H. Lustig, a professor of clinical pediatrics at the 
University of California, San Francisco, “[E]ven those at the lower end of the BMI [body mass 
index] curve are gaining weight. Whatever is happening is happening to everyone, suggesting 
an environmental trigger.”
7 
Many in the medical and exercise physiology communities remain wedded to poor diet 
and lack of exercise as the sole causes of obesity. However, researchers are gathering convincing 
evidence of chemical “obesogens”—dietary, pharmaceutical, and industrial compounds that 
may alter metabolic processes and predispose some people to gain weight.
8,9 
The idea that chemicals in the environment could be contributing to the obesity 
epidemic is often credited to an article by Paula Baillie-Hamilton, published in the Journal of 
Alternative and Complementary Medicine in 2002.
10 Her article presented evidence from earlier 
toxicologic studies published as far back as the 1970s in which low-dose chemical exposures 
were associated with weight gain in experimental animals. At the time, however, the original 
researchers did not focus on the implications of the observed weight gains.
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Obesogens
An Environmental Link 
to ObesityFocus  | Obesogens
The role of environmental chemicals 
in obesity has garnered increased attention 
in academic and policy spheres, and was 
recently acknowledged by the Presidential 
Task Force on Childhood Obesity
11 and 
the National Institutes of Health (NIH) 
Strategic Plan for Obesity Research.
12 “Over 
the past ten years, and especially the past 
five years, there’s been a flurry of new data,” 
says Kristina Thayer, director of the Office 
of Health Assessment and Translation at 
the National Toxicology Program (NTP). 
“There are many studies in both humans 
and animals. The NTP found real biologi-
cal plausibility.” In 2011 the NIH launched 
a 3-year effort to fund research exploring 
the role of environmental chemical expo-
sures in obesity, type 2 diabetes mellitus, 
and metabolic syndrome.
13
The concept of obesogens has spread 
into the public awareness, too, with docu-
mentaries such as “Programmed to be Fat?” 
which aired on the Canadian Broadcasting 
Corporation (CBC) Network in January 
2012 and a session on obesogens at the Soci-
ety of Environmental Journalists annual 
conference in October 2011.
14 
Multiple Modes of Action
The main role of fat cells is to store energy 
and release it when needed. Scientists also 
now know that fat tissue acts as an endo-
crine organ, releasing hormones related to 
appetite and metabolism. Research to date 
suggests different obesogenic compounds 
may have different mechanisms of action, 
some affecting the number of fat cells, oth-
ers the size of fat cells, and still others the 
hormones that affect appetite, satiety, food 
preferences, and energy metabolism.
15 Some 
obesogenic effects may pass on to later gen-
erations through epigenetic changes, heri-
table modifications to DNA and histone 
proteins that affect when and how genes 
are expressed in cells, without altering the 
actual genetic code.
15,16,17
Bruce Blumberg, a biology professor at 
the University of California, Irvine, coined 
the term “obesogen” in 2006 when he dis-
covered that tin-based compounds known 
as organotins predisposed laboratory mice 
to gain weight.
18 “If you give tributyltin 
[TBT] to pregnant mice, their offspring are 
heavier than those not exposed,” he says. 
“We’ve altered the physiology of these off-
spring, so even if they eat normal food, they 
get slightly fatter.” 
Human exposure and health-effect data 
are relatively rare for organotins, but stud-
ies have documented the presence of these 
compounds in human blood,
19 milk,
20 and 
©
 
C
o
n
e
y
l
 
J
a
y
/
P
h
o
t
o
 
R
e
s
e
a
r
c
h
e
r
s
,
 
I
n
c
.
A 64  v o l u m e  120 | n u m b e r  2 | February 2012  •  Environmental Health Perspectives
What Are Obesity and Overweight?
For adults obesity is defined as having a BMI of 30 or more, whereas 
overweight is defined as having a BMI of 25 or more.49 Defining obesity 
is a bit more complicated for children; it depends on the age and sex of 
the child. Children are considered obese if they are at or above the 95th 
percentile of the sex-specific growth charts, and overweight if they are 
between the 85th and 95th percentiles.50
BMI is defined as an individual’s body weight divided by the square of 
his or her height. Although it is not a measure of actual body fat, it can be 
calculated by using callipers to measure three skin folds, then plugging 
those measurements into sex-specific equations. BMI is widely accepted 
as an accurate proxy for body fat percentage in the general adult popula-
tion, and it is the measurement of choice in the scientific literature on 
obesity. Focus  | Obesogens
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21 samples. Although phased out as a 
biocide and marine antifouling agent, TBT 
is still used as a wood preservative and, 
along with dibutyltin, as a stabilizer in poly-
vinyl chloride; it pollutes many waterways 
and contaminates seafood.
22
Blumberg was studying endocrine dis-
ruptors in the early 2000s when he heard 
at a meeting in Japan that TBT causes sex 
reversal in multiple fish species. “I decided 
to test whether TBT activated known nucle-
ar receptors, expecting it to activate a sex 
steroid receptor,” Blumberg says. Instead, it 
activated peroxisome proliferator–activated 
receptor gamma (PPARγ), the master regu-
lator of adipogenesis, the process of cre-
ating adipocytes, or fat cells.
23 PPARγ is 
evolutionarily conserved between mice and 
humans, and it may be particularly sus-
ceptible to chemical “imposters” because it 
has a large ligand-binding pocket that can 
accommodate many chemical structures. 
When a molecule capable of activating the 
receptor enters the pocket, it turns on the 
adipogenic program. 
“If you activate PPARγ in a preadi-
pocyte, it becomes a fat cell. If it already 
is a fat cell, it puts more fat in the cell,” 
Blumberg says. “TBT is changing the 
metabolism of exposed animals, predis-
posing them to make more and bigger fat 
cells.” PPARγ selectively causes multipotent 
stromal cells to differentiate into bone or 
fat, and Blumberg found TBT exposure 
caused these stem cells to show an increased 
commitment to becoming adipocytes at the 
expense of the bone lineage. “The insidious 
thing is that our animals are exposed in 
utero to TBT, then never again, yet TBT 
caused a permanent effect.”
A Growing List of Potential 
Obesogens
Obesity is strongly linked with exposure to 
risk factors during fetal and infant devel-
opment.
15 “There are between fifteen and 
twenty chemicals that have been shown 
to cause weight gain, mostly from devel-
opmental exposure,” says Jerry Heindel, 
who leads the extramural research pro-
gram in obesity at the National Institute of 
Environmental Health Sciences (NIEHS). 
How  ever,  some  obesogens  have  been 
hypothesized to affect adults, with epide-
miologic studies linking levels of chemicals 
in human blood with obesity
24 and studies 
showing that certain pharmaceuticals acti-
vate PPARγ receptors.
15,25
Chemical pesticides in food and water, 
particularly atrazine and DDE (dichloro-
diphenyldichloroethylene—a  DDT 
breakdown product), have been linked to 
increased BMI in children and insulin resis-
tance in rodents.
26,27 Certain pharmaceu-
ticals, such as the diabetes drug Avandia® 
(rosiglitazone), have been linked to weight 
gain in humans and animals,
9,17 as have a 
handful of dietary obesogens, including the 
soy phytoestrogen genistein
28 and mono-
sodium glutamate.
15 
Most  known  or  suspected  obeso-
gens are endocrine disruptors. Many are 
widespread,
29 and exposures are suspected 
or confirmed to be quite common. In one 
2010 study, Kurunthachalam Kannan, a 
professor of environmental sciences at the 
University at Albany, State University of 
New York, documented organotins in a 
designer handbag, wallpaper, vinyl blinds, 
tile, and vacuum cleaner dust collected from 
24 houses.
30 Phthalates, plasticizers that also 
have been related to obesity in humans,
31 
occur in many PVC items as well as in 
scented items such as air fresheners, laundry 
products, and personal care products. 
One  of  the  earliest  links  between 
human fetal development and obesity arose 
from studies of exposure to cigarette smoke 
in utero.
32,33 Although secondhand-smoke 
exposure has decreased by more than half 
over the past 20 years, an estimated 40% 
of nonsmoking Americans still have nico-
tine by-products in their blood, suggesting 
exposure remains widespread.
34 Babies born 
to smoking mothers are frequently under-
weight, but these same infants tend to make 
up for it by putting on more weight during 
infancy and childhood.
35 “If a baby is born 
relatively small for its gestational age, it tries 
to ‘play catch-up’ as it develops and grows,” 
explains Retha Newbold, a developmental 
biologist now retired from the NTP.  
This pattern of catch-up growth is often 
observed with developmental exposure to 
chemicals now thought to be obesogens, 
including diethylstilbestrol (DES), which 
Newbold spent the last 30 years study-
ing, using mice as an experimental model. 
Doctors  prescribed  DES,  a  synthetic 
estrogen, to millions of pregnant women 
from the late 1930s through the 1970s 
to prevent miscarriage. The drug caused 
adverse effects in these women’s children, 
who often experienced reproductive tract 
abnormalities; “DES daughters” also had a 
higher risk of reproductive problems, vagi-
nal cancer in adolescence, and breast cancer 
in adulthood.
36 Newbold discovered that 
low doses of DES administered to mice 
pre- or neonatally also were associated with 
weight gain,
37 altered expression of obesity-
related genes,
38,39 and modified hormone 
levels.
38,39
“What we’re seeing is there’s not a dif-
ference in the number of fat cells, but the 
cell itself is larger after exposure to DES,” 
Newbold says. “There was also a difference 
in how [fat cells] were distributed—where 
they went, how they lined up, and their ori-
entation with each other. The mechanism 
for fat distribution and making fat cells are 
set up during fetal and neonatal life.” 
High-Profile Exposures
Animal studies have also implicated another 
suspected obesogen: bisphenol A (BPA), 
which is found in medical devices, in the 
lining of some canned foods, and in cash 
register receipts.
40 “BPA reduces the number 
 E
ven those at the lower end 
of the BMI curve are gaining 
weight. Whatever is happening 
is happening to everyone, suggesting 
an environmental trigger.
—Robert H. Lustig 
University of California,   
San FranciscoFocus  | Obesogens
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of fat cells but programs them to incorporate 
more fat, so there are fewer but very large fat 
cells,” explains University of Missouri biol-
ogy professor Frederick vom Saal, who has 
studied BPA for the past 15 years. “In ani-
mals, BPA exposure is producing in animals 
the kind of outcomes that we see in humans 
born light at birth: an increase in abdominal 
fat and glucose intolerance.”
Many endocrine disruptors exhibit an 
inverted U-shaped dose–response curve, 
where the most toxic response occurs at 
intermediate doses.
41 However, in a recent 
unpublished study, vom Saal found that 
BPA affected rodent fat cells at very low 
doses, 1,000 times below the dose that reg-
ulatory agencies presume causes no effect in 
humans, whereas at higher doses he saw no 
effect. Receptors typically respond to very 
low levels of hormone, so it makes sense 
that they may be activated by low levels of 
an endocrine mimic, whereas high levels of 
a chemical may actually cause receptors to 
shut down altogether, preventing any fur-
ther response.
41 This is known as “receptor 
downregulation.” As a result, some endo-
crine disruptors have greater effects at low 
than at high doses; different mechanisms 
may be operating.
15
Still another widespread obesogen is 
perfluorooctanoic acid (PFOA), a potential 
endocrine disruptor and known PPARγ 
agonist.
42 “Pretty much everyone in the U.S. 
has it in their blood, kids having higher 
levels than adults, probably because of their 
habits. They crawl on carpets, on furniture, 
and put things in their mouth more often,” 
explains NIEHS biologist Suzanne Fenton. 
PFOA is a surfactant used for reduction 
of friction, and it is also used in nonstick 
cookware, Gore-Tex™ waterproof clothing, 
Scotchgard™ stain repellent on carpeting, 
mattresses, and microwavable food items. In 
2005 DuPont settled a class-action lawsuit 
for $107.6 million after its factory outside 
Parkersburg, West Virginia, tainted nearby 
drinking water supplies with PFOA.
43 In 
December 2011 an independent science 
panel  found  the  first  “probable  link” 
between  PFOA  and  a  human  health 
outcome, pregnancy-induced hypertension
44 
(for more information, see “Pregnancy-
Induced Hypertension ‘Probably Linked’ to 
PFOA Contamination,” p. A59 this issue
45). 
Fenton studied how PFOA levels simi-
lar to those in the tainted drinking water 
affected the hormone levels and weight of 
rodent offspring exposed in utero.
46 “We 
gave pregnant mice PFOA only during 
pregnancy. It has a long half-life, so it hangs 
around during lactation and gets delivered 
in milk to babies,” Fenton says. “Once the 
offspring reached adulthood, they became 
obese, reaching significantly higher weight 
levels than controls.” 
Exposed offspring also had elevated lev-
els of leptin, a hormone secreted by adipose 
tissue that affects appetite and metabolism. 
Leptin normally suppresses appetite, but 
obese people and animals have elevated leptin 
levels, leading researchers to suspect the brain 
can become resistant to its effects.
47 Fenton 
did not observe weight gain when mice were 
exposed to PFOA as adults, although her 
team did find abnormalities in the uterus 
and mammary gland in exposed adults. 
Eye on Prevention 
If exposure during pregnancy predisposes 
people to gain weight, can diet and exercise 
ultimately make any difference? Blumberg 
does not consider the situation hopeless. 
“I would not want to say that obesogen 
exposure takes away free will or dooms 
you to be fat,” he says. “However, it will 
change your metabolic set points for gain-
ing weight. If you have more fat cells and 
propensity to make more fat cells, and 
if you eat the typical high-carbohydrate, 
high-fat diet we eat [in the United States], 
you probably will get fat.” 
Blumberg postulates that the effects 
of early-life exposure are irreversible, and 
those people will fight a life-long battle of 
the bulge. However, if such people reduce 
their exposure to obesogens, they will also 
reduce health effects that may arise from 
ongoing adulthood exposures. Blumberg 
believes it’s good to reduce exposure to all 
kinds of endocrine-disrupting chemicals. 
“Eat organic, filter water, minimize plastic 
in your life,” he says. “If there’s no benefit 
and some degree of risk, why expose your-
self and your family?”
 Heindel hopes the NIH’s new grant-
making effort will yield important discov-
eries. “It’s a very new field, and people are 
always skeptical of new fields,” he says. 
“It’s up to us to get more data to show that 
chemicals are actually interfering with the 
endocrine system that controls weight gain 
and metabolism. And there’s still the ques-
tion of how important is this to humans. 
We’re never going to know until we get 
more data.” 
“What if this was really true and chemi-
cals are having a significant effect on obe-
sity?” muses Heindel. “If we could show 
environmental chemicals play a major role, 
then we could work on reducing exposure 
during sensitive windows, and that could 
have a huge effect [on obesity prevalence].” 
It would change the focus from treating 
adults who are already obese to preventing 
obesity before it starts—a fundamental shift 
in thinking about obesity. 
The NIEHS is crafting priorities for 
research on potential obesogens. Thayer was 
the primary force behind the workshop “The 
Role of Environmental Chemicals in the 
Development of Diabetes and Obesity,”
48 
held in January 2011 and cosponsored by 
the NTP, the Environmental Protection 
If 
you activate PPARγ in a 
preadipocyte, it becomes 
a fat cell. If it already is 
a fat cell, it puts more fat in the cell. 
TBT is changing the metabolism of 
exposed animals, predisposing them 
to make more and bigger fat cells.
—Bruce Blumberg 
University of California, IrvineFocus  | Obesogens
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Agency, and the Food and Drug Admin-
istration National Center for Toxicology 
Research. “The idea was to have the experts 
look through the literature and see which 
might be the most compelling signals, and 
which areas were emerging but warranted 
more research,” Thayer explains. These find-
ings will help identify priorities for future 
research, and a ser ies of papers from the 
workshop are being submitted for publication. 
“We were surprised at the number of 
chemicals that seem to be interacting with 
signaling pathways involved in weight reg-
ulation,” Thayer says. She adds that evi-
dence also suggests these same compounds 
are linked with diabetes and metabolic 
syndrome, “an understudied but natural 
research direction that brings together the 
obesity and diabetes issues.”
Houston-based freelancer Wendee Holtcamp has written 
for Nature, Scientific American, National Wildlife, and other 
magazines.
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In one study by NIEHS biologist Suzanne Fenton, mice exposed prenatally to PFOA were more likely than controls to 
become obese when they reached adulthood.46